These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 30204721)
1. Association of HIV Suppression With Kidney Disease Progression Among HIV-Positive African Americans With Biopsy-Proven Classic FSGS. McMahon BA; Hanouneh M; Chedid A; Fine DM; Chen TK; Foy M; Lucas GM; Estrella MM; Atta MG J Acquir Immune Defic Syndr; 2018 Dec; 79(5):639-643. PubMed ID: 30204721 [TBL] [Abstract][Full Text] [Related]
5. [Glomerular diseases in HIV-infected patients: clinical and morphological evaluation]. Yushchuk ND; Gadzhikuliyeva MM; Volgina GV; Tomilina NA Ter Arkh; 2012; 84(11):30-3. PubMed ID: 23252244 [TBL] [Abstract][Full Text] [Related]
6. Association of APOL1 Genotype with Renal Histology among Black HIV-Positive Patients Undergoing Kidney Biopsy. Atta MG; Estrella MM; Skorecki KL; Kopp JB; Winkler CA; Wasser WG; Shemer R; Racusen LC; Kuperman M; Foy MC; Lucas GM; Fine DM Clin J Am Soc Nephrol; 2016 Feb; 11(2):262-70. PubMed ID: 26668025 [TBL] [Abstract][Full Text] [Related]
7. The changing pattern of glomerular disease in HIV and hepatitis C co-infected patients in the era of HAART. Mohan S; Herlitz LC; Tan J; Cheng JT; Anderson HL; Stokes MB; Markowitz GS; D'Agati VD; Radhakrishnan J Clin Nephrol; 2013 Apr; 79(4):285-91. PubMed ID: 23320974 [TBL] [Abstract][Full Text] [Related]
8. Focal segmental glomerulosclerosis, excluding atypical lesion, is a predictor of renal outcome in patients with membranous nephropathy: a retrospective analysis of 716 cases. He HG; Wu CQ; Ye K; Zeng C; Huang YY; Luo SW; Yin W; Ye QR; Peng XM BMC Nephrol; 2019 Aug; 20(1):328. PubMed ID: 31438882 [TBL] [Abstract][Full Text] [Related]
9. The effects of add-on corticosteroids on renal outcomes in patients with biopsy proven HIV associated nephropathy: a single centre study from South Africa. Wearne N; Swanepoel CR; Duffield MS; Davidson BJ; Manning K; Tiffin N; Boulle A; Rayner BL; Naidu P; Okpechi IG BMC Nephrol; 2019 Feb; 20(1):44. PubMed ID: 30728003 [TBL] [Abstract][Full Text] [Related]
10. Course and prognosis of human immunodeficiency virus-associated nephropathy. Carbone L; D'Agati V; Cheng JT; Appel GB Am J Med; 1989 Oct; 87(4):389-95. PubMed ID: 2801729 [TBL] [Abstract][Full Text] [Related]
11. The clinical epidemiology and course of the spectrum of renal diseases associated with HIV infection. Szczech LA; Gupta SK; Habash R; Guasch A; Kalayjian R; Appel R; Fields TA; Svetkey LP; Flanagan KH; Klotman PE; Winston JA Kidney Int; 2004 Sep; 66(3):1145-52. PubMed ID: 15327410 [TBL] [Abstract][Full Text] [Related]
13. The spectrum of HIV-related nephropathy in children. Ramsuran D; Bhimma R; Ramdial PK; Naicker E; Adhikari M; Deonarain J; Sing Y; Naicker T Pediatr Nephrol; 2012 May; 27(5):821-7. PubMed ID: 22205506 [TBL] [Abstract][Full Text] [Related]
14. Comparison of risk factors and outcomes in HIV immune complex kidney disease and HIV-associated nephropathy. Foy MC; Estrella MM; Lucas GM; Tahir F; Fine DM; Moore RD; Atta MG Clin J Am Soc Nephrol; 2013 Sep; 8(9):1524-32. PubMed ID: 23685946 [TBL] [Abstract][Full Text] [Related]
15. Determinants of incident chronic kidney disease and progression in a cohort of HIV-infected persons with unrestricted access to health care. Ganesan A; Krantz EM; Huppler Hullsiek K; Riddle MS; Weintrob AC; Lalani T; Okulicz JF; Landrum M; Agan B; Whitman TJ; Ross MJ; Crum-Cianflone NF; HIV Med; 2013 Feb; 14(2):65-76. PubMed ID: 22808988 [TBL] [Abstract][Full Text] [Related]
16. Human immunodeficiency virus-associated nephropathy: a primary care perspective. Olatinwo T; Hewitt RG; Venuto RC Arch Intern Med; 2004 Feb; 164(3):333-6. PubMed ID: 14769631 [TBL] [Abstract][Full Text] [Related]
17. HIV-associated nephropathy: clinical presentation, pathology, and epidemiology in the era of antiretroviral therapy. Wyatt CM; Klotman PE; D'Agati VD Semin Nephrol; 2008 Nov; 28(6):513-22. PubMed ID: 19013322 [TBL] [Abstract][Full Text] [Related]
18. Non-muscle myosin heavy chain 9 gene MYH9 associations in African Americans with clinically diagnosed type 2 diabetes mellitus-associated ESRD. Freedman BI; Hicks PJ; Bostrom MA; Comeau ME; Divers J; Bleyer AJ; Kopp JB; Winkler CA; Nelson GW; Langefeld CD; Bowden DW Nephrol Dial Transplant; 2009 Nov; 24(11):3366-71. PubMed ID: 19567477 [TBL] [Abstract][Full Text] [Related]
19. Highly active antiretroviral therapy and the epidemic of HIV+ end-stage renal disease. Schwartz EJ; Szczech LA; Ross MJ; Klotman ME; Winston JA; Klotman PE J Am Soc Nephrol; 2005 Aug; 16(8):2412-20. PubMed ID: 15987747 [TBL] [Abstract][Full Text] [Related]
20. Is the prevalence of HIV-associated nephropathy decreasing? Ahuja TS; Borucki M; Funtanilla M; Shahinian V; Hollander M; Rajaraman S Am J Nephrol; 1999; 19(6):655-9. PubMed ID: 10592359 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]